GlaxoSmithKline Pakistan Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for GlaxoSmithKline Pakistan stock have an average target of Rs 510.00, which predicts a 49.76% increase from the current stock price of 340.54.

Price Target: Rs 510.00 (+49.76%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	Rs 510.00	Rs 510.00	Rs 510.00	Rs 510.00
Change	+49.76%	+49.76%	+49.76%	+49.76%

Analyst Ratings

The average analyst rating for GlaxoSmithKline Pakistan stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	3	3	3	3	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Financial Forecast

Revenue This Year

68.81B

from 65.90B

4.42%

from 65.90B

Revenue Next Year

75.92B

from 68.81B

10.33%

from 68.81B

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	36.66B	41.84B	49.66B	61.19B	65.90B	68.81B
Revenue Growth	4.48%	14.13%	18.69%	23.21%	7.70%	4.42%
Gross Profit	9.87B	7.34B	3.42B	15.28B	24.28B	24.77B
Gross Margin	26.93%	17.53%	6.88%	24.97%	36.85%	36.00%
Operating Income	6.87B	5.07B	1.96B	10.25B	16.36B	18.75B
Net Income	5.35B	2.46B	533.95M	6.54B	10.03B	10.49B
Dividend / Share	7.00	-	-	10.00	17.00	18.56
Dividend Growth	7.69%	-	-	-	70.00%	9.18%
No. Analysts	-	-	-	-	-	1

Financial currency is PKR.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	68.8B
Avg	68.8B
Low	68.8B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	4.4%
Avg	4.4%
Low	4.4%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

Chart

EPS Growth	2027	2028
High	-
Avg	-
Low	-